key: cord-0916184-y1lze2lb authors: Cristelli, Marina P.; Viana, Laila A.; Fortaleza, Carlos M.; Granato, Celso; Nakamura, Monica R.; Santos, Daniel W.C.L.; Foresto, Renato Demarchi; Tedesco‐Silva, Helio; Medina‐Pestana, Jose title: Lower seroprevalence for SARS‐CoV‐2‐specific antibodies among kidney transplant recipients compared to the general population in the city of Sao Paulo, Brazil date: 2021-08-07 journal: Transpl Infect Dis DOI: 10.1111/tid.13706 sha: 0a3a44100c1e70b685497d9e973a963042a80be3 doc_id: 916184 cord_uid: y1lze2lb BACKGROUND: Kidney transplant recipients have higher COVID‐19 associated mortality compared to the general population. However, as only symptomatic patients seek medical attention, the current level of exposure, the main sources of acquisition, and the behavior of humoral immunity over time are poorly understood. METHODS: This cross‐sectional prospective single‐center study recruited kidney transplant recipients of any age living in Sao Paulo. A sample size of 401 patients was calculated considering the 17.2% seroprevalence in the municipality population from a published survey, a 95% confidence interval and an absolute error of 2%. RESULTS: Of the 2636 eligible patients, 416 were included. The seroprevalence for IgG anti‐SARS‐CoV‐2 was 8.2%. Seroconversion rate decreased with increasing age, from 15.7% (18–35 years) to 8.3% (36–60 years) and 4.2% (>60 years, p = 0.042). Seropositivity among previously confirmed COVID‐19 patients was 68.4%, followed by 9.4% in those with flu‐like symptoms and only 4.6% among asymptomatic patients (p < 0.0001). Seroprevalence was significantly higher among patients reporting household contact (p = 0.018). Twenty‐seven from the 34 IgG+ patients had a second test after 59 (IQR 50–63) days, and, in 33%, the IgG index became below the positivity threshold. CONCLUSIONS: In this cohort of kidney transplant recipients, the seroprevalence for IgG anti‐SARS‐CoV‐2 was lower than that of the general population, decreased with ageing, and was associated with household contacts. In a considerable proportion of the patients, there was a significant decay in the IgG levels in a short period of time. Therefore, preventive strategies, such as prioritization for vaccination, should be urgently considered. Population-based data on the seroprevalence of antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are now available worldwide, showing wide variability depending on age, ethnicity, socio-economic level, geographic region, and timing of the survey during the pandemic. 1, 2 In Brazil, a country with one of the highest number of cases, 3 a large cross-sectional study including more than 30,000 households from 133 sentinel cities in all states, showed an increase in seroprevalence from 1.9% in May to 3.1% in June, 2020. 4 Infection rates are higher among health professionals 2, 5, 6 and younger people due to higher environmental and mobility exposure, respectively. 1, 4 Transplant recipients have a higher COVID-19-associated mortality compared to the general population. [7] [8] [9] Yet, because only symptomatic patients seek health-care assistance, the actual level of exposure is not known. Whether routine and unscheduled medical visits to transplant centers increase the risk of infection, compared to the general population, is still unknown. In Sao Paulo, a city with more than 12 million inhabitants (8, 407, 202 inhabitants aged 18 or over) and a population density of 8,054/kmš, a serosurvey with six phases was established to estimate the percentage of adults infected by SARS-CoV-2. Seroprevalence increased from 11.5% in June (15th to 24th) to 17.9% in July (20th to 29th), and to 26.2% in October (1st to 10th) 2020. 10 Therefore, we sought to determine and compare the seroprevalence for SARS-CoV-2 among kidney transplant recipients living in the city taking advantage of this survey in the general population. We also explored the risk factors associated with the presence of a positive IgG serology and the antibodies titers in a follow up samples two months apart. This was a cross-sectional prospective single-center study. The sample size calculation was performed using the OpenEpi software, version 3.01, considering the total population of eligible patients (n = 2,636) and the 17.2% prevalence of the event of interest (seropositivity) in the general population according to the municipal epidemio-logical survey. 10 With a prespecified confidence interval of 95.0% and an absolute error of 2%, the expected total sample size was 401 people. Of the 2636 kidney transplant recipients eligible for the survey, 19% live in the North, 32% in the South, 3% in the Center, 19% in the East, and 27% in the West region of the city. Since regional differences may influence the degree of exposure to the infection, the study population was constituted to represent the regional distribution of patients. Therefore, all the patients with a scheduled in-person outpatient visit beginning of September 1st, 2020 were screened until a representative sample of each city region was completed, which occurred on 25th of September 2020. All enrolled patients answered a questionnaire containing the follow- Mixed ethnicity refers to people of mixed race between Caucasians and Africans. The presence of anti-SARS-CoV-2 antibodies (IgG) was determined in a serum sample obtained at the scheduled in-person outpatient visit. Patients with a positive test were invited to provide a follow-up sample two months later to analyze antibody titers decay. Anti-SARS-CoV-2 antibody (IgG) was determined using the Abbott SARS-CoV-2 IgG assay on the Abbott Architect system. The assay is a chemiluminescent microparticle immunoassay for qualitative detection of IgG against the SARS-CoV-2 nucleoprotein. The results were interpreted as positive according to the manufacturer's instructions with a cut-off antibody index of 1.68 arbitrary units. Continuous variables were presented as median and interquartile ranges (IQR). Comparisons were made using the non-parametric were not included in the numerator; therefore, seroprevalence rates are expected to be higher than attack rates. Statistical analysis was performed using the SPSS program v. 22.0 (SPSS Inc., Chicago, IL, USA). Of the 2636 eligible patients, 552 subjects with a scheduled in-person appointment were screened to construct the representative regional In this cohort (n = 416), the seroprevalence for SARS-CoV-2 infec- Patients showing seroconversion were younger, primarily due to a lower representation of the older than 60 years stratum compared to IgG-patients. There were no differences in gender, ethnicity, and blood type, history of diabetes mellitus, donor type, and time after transplantation. There were also no differences in environmental conditions such as regions of residence, health care profession, and contact tracing. Notably, compared to IgG− patients, a higher proportion of IgG+ patients had previous confirmed SARS-CoV-2 infection (38% vs. 2%, p < 0.0001, Table 1 ). In this cohort of patients, the seroprevalence decreased with increasing age, tendency not observed in the serosurvey conducted in the city of Sao Paulo (seroprevalence randomly ranging from 15.8% to 22% across the age strata). 10 Possible explanations include a selection bias, because older people have higher COVID-19-associated mortality and the relationship between immunosenescence and lower vaccine immune responses. 16 Celso Granato, and Helio Tedesco-Silva analyzed the data. Marina P. Cristelli, Laila A Silva drafted and revised the paper. All authors approved the final version of the manuscript Fortaleza equally contributed to the study Estimated SARS-CoV-2 Seroprevalence in the US as of Population-based seroprevalence surveys of anti-SARS-CoV-2 antibody: an up-to-date review Health Surveillance Secretariat. Ministry of Health of. Coronavirus -COVID-19 SARS-CoV-2 antibody prevalence in Brazil: results from two successive nationwide serological household surveys Seroprevalence of SARS-CoV-2 among frontline health care personnel in a multistate hospital network -13 Academic Medical Centers High prevalence of asymptomatic COVID-19 infection in hemodialysis patients detected using serologic screening COVID-19 and solid organ transplantation: a review article An initial report from the French SOT COVID Registry suggests high mortality due to Covid-19 in recipients of kidney transplants. Kidney Int TANGO Study Group. COVID-19 and kidney transplantation: results from the TANGO International Transplant Consortium Serial soroepidemiological survey to monitor the prevalence of SARS-CoV-2 infection in the Municipality of São Paulo, SP, Brazil. Accessed Mar 03, 2021. www.monitoramentocovid19.org 11. São Paulo. Secretaria Municipal de Saúde. Núcleo de comunicação do comitê de crise para enfrentamento da COVID-19 Kidney transplantation in the time of COVID-19: dilemmas, experiences, and perspectives AST ID Community of. Vaccination of solid organ transplant candidates and recipients: guidelines from the American society of transplantation infectious diseases community of practice Association between ABO blood groups and COVID-19 infection, severity and demise: a systematic review and meta-analysis Spread of SARS-CoV-2 in the Icelandic Population Understanding immunosenescence and its impact on vaccination of older adults Rapid decay of anti-SARS-CoV-2 antibodies in persons with mild covid-19 Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections Ebola virus antibody decay-stimulation in a high proportion of survivors Evolution of antibody immunity to SARS-CoV-2 Humoral immune responses in COVID-19 patients: a window on the state of the art The authors declare that they have no competing interests. Marina P. Cristelli https://orcid.org/0000-0002-2813-0400 Additional supporting information may be found online in the Supporting Information section at the end of the article.